NO952336D0 - Insulin analoger - Google Patents

Insulin analoger

Info

Publication number
NO952336D0
NO952336D0 NO952336A NO952336A NO952336D0 NO 952336 D0 NO952336 D0 NO 952336D0 NO 952336 A NO952336 A NO 952336A NO 952336 A NO952336 A NO 952336A NO 952336 D0 NO952336 D0 NO 952336D0
Authority
NO
Norway
Prior art keywords
insulin analogues
analogues
insulin
Prior art date
Application number
NO952336A
Other languages
English (en)
Norwegian (no)
Other versions
NO952336L (no
Inventor
Ronald Eugene Chance
Li Fan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO952336D0 publication Critical patent/NO952336D0/no
Publication of NO952336L publication Critical patent/NO952336L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO952336A 1992-12-18 1995-06-13 Insulin analoger NO952336L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99565992A 1992-12-18 1992-12-18
PCT/US1993/012237 WO1994014461A1 (fr) 1992-12-18 1993-12-15 Analogues d'insuline

Publications (2)

Publication Number Publication Date
NO952336D0 true NO952336D0 (no) 1995-06-13
NO952336L NO952336L (no) 1995-06-13

Family

ID=25542078

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952336A NO952336L (no) 1992-12-18 1995-06-13 Insulin analoger

Country Status (14)

Country Link
EP (1) EP0605983A3 (fr)
JP (1) JPH08504820A (fr)
CN (1) CN1094059A (fr)
AU (1) AU680462B2 (fr)
BR (1) BR9307687A (fr)
CA (1) CA2151134A1 (fr)
CZ (1) CZ158895A3 (fr)
FI (1) FI953001A (fr)
HU (1) HUT71583A (fr)
MX (1) MX9307991A (fr)
NO (1) NO952336L (fr)
PL (1) PL310007A1 (fr)
WO (1) WO1994014461A1 (fr)
ZA (1) ZA939477B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559094A (en) * 1994-08-02 1996-09-24 Eli Lilly And Company AspB1 insulin analogs
CN1125081C (zh) * 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 重组天然和新型人胰岛素及其制备方法
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
EP3228320B1 (fr) 2008-10-17 2019-12-18 Sanofi-Aventis Deutschland GmbH Combinaison d'une insuline et d'un antagoniste glp 1
UY33025A (es) 2009-11-13 2011-06-30 Sanofi Aventis Deustschland Gmbh Composicion farmaceutica que comprende un agonista de glp-1 metionina
AR080669A1 (es) 2009-11-13 2012-05-02 Sanofi Aventis Deutschland Composicion farmaceutica que comprende un agonista de glp-1, una insulina y metionina
MX339614B (es) 2010-08-30 2016-06-02 Sanofi - Aventis Deutschland GmbH Uso de ave0010 para la fabricacion de un medicamento para el tratamiento de la diabetes mellitus tipo 2.
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
RU2650616C2 (ru) 2011-08-29 2018-04-16 Санофи-Авентис Дойчланд Гмбх Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
WO2014052451A2 (fr) 2012-09-26 2014-04-03 Indiana University Research And Technology Corporation Dimères analogues de l'insuline
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
IL102240A0 (en) * 1991-06-21 1993-01-14 Lilly Co Eli Insulin analogs

Also Published As

Publication number Publication date
EP0605983A3 (fr) 1995-06-07
CA2151134A1 (fr) 1994-07-07
PL310007A1 (en) 1995-11-13
HU9501762D0 (en) 1995-08-28
WO1994014461A1 (fr) 1994-07-07
HUT71583A (en) 1995-12-28
CZ158895A3 (en) 1995-12-13
BR9307687A (pt) 2002-02-19
FI953001A0 (fi) 1995-06-16
EP0605983A2 (fr) 1994-07-13
AU680462B2 (en) 1997-07-31
JPH08504820A (ja) 1996-05-28
AU5827994A (en) 1994-07-19
MX9307991A (es) 1994-08-31
ZA939477B (en) 1995-06-19
FI953001A (fi) 1995-06-16
CN1094059A (zh) 1994-10-26
NO952336L (no) 1995-06-13

Similar Documents

Publication Publication Date Title
BR9305077A (pt) Seringa hipodémica
ATE237635T1 (de) Acylierte insulinanalogen
FI956308A0 (fi) Injektioruisku
DK186089D0 (da) Sproejter
FI104235B1 (fi) Ruisku
DE69222622D1 (de) Spritze
FI933933A (fi) Ampull
BR9306974A (pt) Seringa
DE59308356D1 (de) Spritze
FI953001A (fi) Insuliinianalogeja
DE69304645D1 (de) Kanuele
FI943581A (fi) Ruisku
DE69309570D1 (de) Spritze
NO922376D0 (no) Insulinanaloger
KR920021041U (ko) 세척기
NO950721D0 (no) Insulinanaloger
NO942783D0 (no) Spröyte
KR940001042U (ko) 앰플(Ampoule)
KR950008187U (ko) 화살식 동물 주사기
SE9202756D0 (sv) Spruta
KR930017636U (ko) 세척기
BR9200932A (pt) Seringa
DK265590A (da) Insulinanaloger
ATE100824T1 (de) Insulin-analoge.
NO904841D0 (no) Insulinanaloger.